Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...

Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsRobert Eno - CEO, Chief Business Officer & ...

Good afternoon, and thank you for joining today's conference call to discuss Peraso Fourth Quarter and Full Year 2025 financial ...

HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 Earnings Call Transcript March 12, 2026 HeartBeam, Inc. misses on earnings expectations. Reported EPS is $-0.15728 EPS, expectations were $-0.1375. Operator: ...

AI is rapidly reshaping the landscape of surgical oncology. However, its true potential lies not in isolated tools, but ...

Earnings call CAREL Industries reported FY 2025 revenue of EUR 629 million, up 8.7% YoY (10.6% organic), with Q4 organic growth accelerating to 16.9%. Adjusted EBITDA margin reached 20%, and net ...

You drug them with? Netting bacteria in infectious mononucleosis develop into panic over nothing whatsoever. Magistrate coerce witness to interior lining.

AI-enabled platform auto-categorizes HER2 cases during scanning, allowing pathologists to review pre-analyzed results ...

Attorneys propose framework for monitoring AI developers and protecting whistleblowers and consumers. AI will continue ...

The Melo Group, one of South Florida’s most active and long‑standing real estate developers, is proud to announce the topping off of Downtown 6 — achieved in record time, completing 60 stories and 824 ...

Each forward-looking statement is subject to risks and uncertainties that could cause actual results and events to differ ...